Related Experiment Video
Updated: Jul 20, 2025

07:06
Particle Agglutination Method for Poliovirus Identification
Published on: April 20, 2011
15.4K
[Position of killed polio vaccine in the Expanded Program on Immunization]
1Président honoraire de la SFMTSI, Société francophone de médecine tropicale et santé internationale (ancienne SPE), Hôpital Pitié-Salpêtrière, Pavillon Laveran, 47-83 Boulevard de l'Hôpital, 75651 Paris cedex 13, France.
Medecine Tropicale Et Sante Internationale
|August 1, 2023
Summary
This study revisits a 1988 mobile Expanded Program on Immunization (EPI) strategy using the injectable polio vaccine. It explains the rationale for publishing this historical data on improving vaccine delivery efficiency in Africa.
Area of Science:
- Tropical medicine
- Global health
- Vaccine delivery systems
Context:
- The article addresses the publication of a 1988 study on mobile immunization strategies in Africa.
- It highlights the long delay between study completion and publication.
Purpose:
- To provide the rationale for publishing historical data on mobile Expanded Program on Immunization (EPI) strategies.
- To discuss the relevance of past vaccine delivery methods in the context of current public health challenges.
Summary:
- The study evaluated a mobile Expanded Program on Immunization (EPI) strategy utilizing the injectable polio vaccine.
- The research, conducted in 1988, aimed to enhance the efficiency of vaccine delivery in African regions.
- The article explains the decision to publish these findings decades later.
Impact:
- Revisiting historical immunization data can inform current strategies for vaccine delivery in resource-limited settings.
- Understanding past challenges and successes in mobile EPI can contribute to ongoing efforts to improve global child health outcomes.
Related Concept Videos
Vaccinations
44.7K
Overview
44.7K
Cancer Vaccines
405
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
405
Development of Immunocompetence
345
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
345

